IBDEI0AV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4866,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,4866,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,4867,0)
 ;;=E10.341^^24^305^46
 ;;^UTILITY(U,$J,358.3,4867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4867,1,3,0)
 ;;=3^Diabetes Type 1 w/ Severe Nonprlf Diabetic Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,4867,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,4867,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,4868,0)
 ;;=E10.349^^24^305^47
 ;;^UTILITY(U,$J,358.3,4868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4868,1,3,0)
 ;;=3^Diabetes Type 1 w/ Severe Nonprlf Diabetic Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,4868,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,4868,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,4869,0)
 ;;=E10.51^^24^305^27
 ;;^UTILITY(U,$J,358.3,4869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4869,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Peripheral Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,4869,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,4869,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,4870,0)
 ;;=E10.52^^24^305^28
 ;;^UTILITY(U,$J,358.3,4870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4870,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Peripheral Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,4870,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,4870,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,4871,0)
 ;;=E10.622^^24^305^49
 ;;^UTILITY(U,$J,358.3,4871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4871,1,3,0)
 ;;=3^Diabetes Type 1 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,4871,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,4871,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,4872,0)
 ;;=E10.628^^24^305^48
 ;;^UTILITY(U,$J,358.3,4872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4872,1,3,0)
 ;;=3^Diabetes Type 1 w/ Skin Complication NEC
 ;;^UTILITY(U,$J,358.3,4872,1,4,0)
 ;;=4^E10.628
 ;;^UTILITY(U,$J,358.3,4872,2)
 ;;=^5002618
 ;;^UTILITY(U,$J,358.3,4873,0)
 ;;=E10.630^^24^305^43
 ;;^UTILITY(U,$J,358.3,4873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4873,1,3,0)
 ;;=3^Diabetes Type 1 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,4873,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,4873,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,4874,0)
 ;;=E10.638^^24^305^42
 ;;^UTILITY(U,$J,358.3,4874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4874,1,3,0)
 ;;=3^Diabetes Type 1 w/ Oral Complication NEC
 ;;^UTILITY(U,$J,358.3,4874,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,4874,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,4875,0)
 ;;=E10.649^^24^305^35
 ;;^UTILITY(U,$J,358.3,4875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4875,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,4875,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,4875,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,4876,0)
 ;;=E10.65^^24^305^33
 ;;^UTILITY(U,$J,358.3,4876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4876,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,4876,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,4876,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,4877,0)
 ;;=E10.8^^24^305^51
 ;;^UTILITY(U,$J,358.3,4877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4877,1,3,0)
 ;;=3^Diabetes Type 1 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,4877,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,4877,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,4878,0)
 ;;=99201^^25^306^1
 ;;^UTILITY(U,$J,358.3,4878,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4878,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,4878,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,4879,0)
 ;;=99202^^25^306^2
 ;;^UTILITY(U,$J,358.3,4879,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,4879,1,1,0)
 ;;=1^Expanded Problem Focus
